Comparison of the ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System With a Drug- Eluting Metal Stent (XienceTM) in Acute ST-Elevation Myocardial Infarction
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2018
Price : $35 *
At a glance
- Drugs Everolimus (Primary)
- Indications Myocardial infarction; Thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms TROFI-II
- 17 Jan 2018 Status changed from active, no longer recruiting to completed.
- 10 Aug 2017 Planned End Date changed from 1 Sep 2017 to 1 Oct 2017.
- 23 Sep 2015 Results published in the European Heart Journal